课题基金 / 基金详情

项目摘要

项目成果

Robert M Sharkey的其他基金

相似基金

相关文献

中文摘要
翻译
剂量学核心已经在CMMI建立了大约6年。这个核心的目的是为了 制定处理CMMI赞助的药代动力学和剂量学数据的标准程序 临床试验,但这一核心也协助CMMI的研究人员进行临床前评估。核心是 负责CMMI成像协议所要求的方法学方面的首批培训现场,以及 确保所有设备,包括内部和外部的设备,都得到了适当的校准和维护。这个 CORE接收CMMI调查站点进行的所有成像研究的数字和硬拷贝 临床方案。然后,核心将审查这些图像,并准备来自哪些感兴趣区域 可以生成时间-活动曲线。一名训练有素的核医生和一名核医学技术专家 监督这项工作。作为一项额外的质量保证检查,CMMI还会通过 合格的辐射健康物理学家(本计划项目的Jeff Siegel博士)。这个核心也是 负责处理药代动力学数据。
英文摘要
The Dosimetry Core has been established at CMMI for about 6 years. The purpose of this core was to develop standard procedures for processing pharmacokinetic and dosimetry data for CMMI-sponsored clinical trials, but this core also assists investigators at CMMI in preclinical evaluation. The core is responsible for first training sites in the methodology that CMMI requires of its imaging protocols and ensures all equipment, both internally and at extramural sites, are properly calibrated and maintained. The core receives digital and hard copies of all imaging studies performed by investigational sites for CMMI clinical protocols. The core will then reviews these images and prepares regions of interest from which time-activity curves can be generated. A trained nuclear physician and a nuclear medicine technologist supervise this work. As an additional quality assurance check, CMMI also has these data reviewed by a qualified radiation health physicist (for this Program Project, Dr. Jeff Siegel). This core also is responsible for processing pharmacokinetic data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biospecific Antibody Pretargeting for NHL
Molecular Engineering and Antibody Production
Bispecific Antibody Pretargeted Therapy of Pancreatic Cancer
Bispecific Antibody Pretargeting for Therapy
海外基金